For Research Use Only. Not for Human or Veterinary Use.
Overview
A master reference of the dosing parameters reported in the research literature for every compound in this database — dose range, route, frequency, cycle length, half-life, solvent and storage — grouped by category. These are reconstitution-oriented reference figures for laboratory research only, not dosing guidance for human or veterinary use.
📋How to Read This Table
Each category below lists its compounds side by side. Figures are typical research values from the literature; always cross-check the individual compound page and its Certificate of Analysis.
💊GLP-1 Receptor Agonists
Property
Tirzepatide
Retatrutide
Semaglutide
Research dose
0.25–2 mg/wk
0.25–1.2 mg/wk
0.25–2.4 mg/wk
Route
SC
SC
SC / oral
Frequency
Weekly
Weekly
Weekly (SC)
Cycle
12–104 wk (clinical)
12–104 wk (clinical)
12–104 wk (clinical)
Half-life
~ 5 days
~ 6 days
~ 7 days
Solvent
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Storage
Powder −20°C; recon 2–8°C 14 d
Powder −20°C; recon 2–8°C 14 d
Powder −20°C; recon 2–8°C 14 d
💊Cosmetic & Topical Peptides
Property
GHK-Cu
Matrixyl
Argireline
Matrixyl 3000
SNAP-8
Research dose
0.1–3% (topical)
0.5–5% (topical)
1–10% (topical)
1–8% (topical)
1–10% (topical)
Route
Topical
Topical
Topical
Topical
Topical
Frequency
1–2×/day
1–2×/day
1–2×/day
1–2×/day
1–2×/day
Cycle
Ongoing (topical)
Ongoing (topical)
Ongoing (topical)
Ongoing (topical)
Ongoing (topical)
Half-life
~ 15 min (GHK)
—
—
—
—
Solvent
Formulation base
Emulsion / co-solvent
Water / formulation base
Emulsion / co-solvent
Water / formulation base
Storage
Powder −20°C; solution 2–8°C
Powder −20°C; emulsion 12+ mo
Powder −20°C; solution 2–8°C
Powder −20°C; emulsion 12+ mo
Powder −20°C; solution 2–8°C
💊Tissue Repair & Regenerative
Property
BPC-157
TB-500 (Ac-SDKP)
Research dose
10–50 µg/kg
1–5 mg
Route
SC / oral
SC / IM
Frequency
1–2×/day
1–2×/wk
Cycle
2–8 wk
4–8 wk
Half-life
~ 15 min
~ 2–6 h
Solvent
Bacteriostatic water
Bacteriostatic water
Storage
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
💊Mitochondrial & Metabolic
Property
MOTS-c
SS-31 (Elamipretide)
Humanin
AOD-9604
Research dose
5–15 mg
0.5–2 mg
2–8 mg
300–1000 µg
Route
SC / IP
SC / IV
SC / IV
SC
Frequency
1–2×/wk
Daily
1–2×/day
Daily
Cycle
4–12 wk
2–8 wk
4–12 wk
4–12 wk
Half-life
~ 2–4 h
~ 2–4 h
~ 1–3 h
~ 2–4 h
Solvent
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Storage
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
💊Growth Factors & Signaling
Property
MK-677 (Ibutamoren)
Ipamorelin
GHRP-2
GHRP-6
CJC-1295
Sermorelin
Research dose
10–25 mg
200–500 µg
100–300 µg
100–300 µg
1–2 mg
200–500 µg
Route
Oral
SC
SC
SC
SC
SC / IV
Frequency
Daily
2–3×/day
2–3×/day
2–3×/day
Every 5–8 d
Daily
Cycle
12–52 wk
8–16 wk
8–16 wk
8–16 wk
8–16 wk
12–24 wk
Half-life
~ 24 h
~ 2 h
~ 30 min
~ 30 min
~ 6–8 days
~ 12 min
Solvent
N/A (oral)
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Bacteriostatic water
Storage
Solid 2–8°C, dry, dark
Powder −20°C; recon 2–8°C
Powder −20°C; recon 2–8°C
Powder −20°C; recon 2–8°C
Powder −20°C; recon 2–8°C
Powder −20°C; recon 2–8°C
💊Cognitive & Neuro Regulation
Property
Semax
Selank
Noopept
Cerebrolysin
Research dose
200–600 µg
200–600 µg
10–20 mg
5–20 mL
Route
Intranasal
Intranasal
Oral / SL
IV / IM
Frequency
1–2×/day
1–2×/day
2–3×/day
3–7×/wk
Cycle
1–3 mo
1–3 mo
1–3 mo
4–12 wk
Half-life
~ 30 min
~ 20 min
~ 2–5 h
~ 4–6 h
Solvent
Bacteriostatic water
Bacteriostatic water
Water / saline
Pre-mixed
Storage
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
Solid 2–8°C, dry, dark
15–25°C, sealed, dark
💊Sleep & Pineal Peptides
Property
Epitalon
Pinealon
Research dose
5–10 mg
5–10 mg
Route
SC
SC
Frequency
Daily (5–10 d)
Daily (5–10 d)
Cycle
2–4×/yr
2–4×/yr
Half-life
~ 30–60 min
~ 20–40 min
Solvent
Bacteriostatic water
Bacteriostatic water
Storage
Powder −20°C; recon 2–8°C 7 d
Powder −20°C; recon 2–8°C 7 d
🧮Dosing Units & Syringe Conversion
1 mg = 1000 µg. Volume to withdraw (mL) = dose ÷ concentration. On a 1 mL (100-unit) insulin syringe, 0.1 mL = 10 units.
Concentration
250 µg dose =
500 µg dose =
1 mg dose =
2.5 mg/mL
0.10 mL (10 u)
0.20 mL (20 u)
0.40 mL (40 u)
5 mg/mL
0.05 mL (5 u)
0.10 mL (10 u)
0.20 mL (20 u)
⚠️Important Notes
These are research reference ranges, not recommendations for human or veterinary use.
Cosmetic peptides are expressed as topical formulation percentages, not injected doses.
MK-677 and Noopept are oral; Cerebrolysin is a pre-mixed solution dosed by volume.
For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.